NLS Pharmaceutics AG
NASDAQ:NLSP

Watchlist Manager
NLS Pharmaceutics AG Logo
NLS Pharmaceutics AG
NASDAQ:NLSP
Watchlist
Price: 0.141 USD -15.16%
Updated: Jun 3, 2024
NLSP
/
Income Statement
/
Research & Development

NLS Pharmaceutics AG
Research & Development

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

NLS Pharmaceutics AG
Research & Development Peer Comparison

Comparables:
NOVN
ROG
S
SDZ

Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
NLS Pharmaceutics AG
NASDAQ:NLSP
Research & Development
-$5.9m
CAGR 3-Years
-289%
CAGR 5-Years
-33%
CAGR 10-Years
N/A
Novartis AG
SIX:NOVN
Research & Development
-$10.8B
CAGR 3-Years
N/A
CAGR 5-Years
-5%
CAGR 10-Years
-2%
Roche Holding AG
SIX:ROG
Research & Development
-CHf13.2B
CAGR 3-Years
-3%
CAGR 5-Years
-4%
CAGR 10-Years
-4%
S
Sandoz Group AG
SIX:SDZ
Research & Development
-$915m
CAGR 3-Years
-2%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is NLS Pharmaceutics AG's Research & Development?
Research & Development
-5.9m USD

Based on the financial report for Dec 31, 2023, NLS Pharmaceutics AG's Research & Development amounts to -5.9m USD.

What is NLS Pharmaceutics AG's Research & Development growth rate?
Research & Development CAGR 5Y
-33%

Over the last year, the Research & Development growth was 34%. The average annual Research & Development growth rates for NLS Pharmaceutics AG have been -289% over the past three years , -33% over the past five years .

ALPHA SPREAD
Join more than 143,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.